The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Eligibility for second-line therapy in patients with advanced hepatocellular carcinoma (aHCC): A BC Cancer population-based study.
 
Erica S. Tsang
No Relationships to Disclose
 
Janine Marie Davies
Honoraria - Bayer; Bayer; Bayer; Bayer
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Ipsen; Ipsen; Ipsen; Ipsen; Shire; Shire; Shire; Shire
Speakers' Bureau - Roche Canada; Roche Canada; Roche Canada; Roche Canada
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer
 
Jonathan M. Loree
Consulting or Advisory Role - AMGEN; AMGEN; AMGEN; AMGEN; Bayer; Bayer; Bayer; Bayer; Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
 
Howard John Lim
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Ipsen; Ipsen; Ipsen; Ipsen; Lilly/ImClone; Lilly/ImClone; Lilly/ImClone; Lilly/ImClone; Merck; Merck; Merck; Merck; Roche Canada; Roche Canada; Roche Canada; Roche Canada; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Eisai; Eisai; Eisai; Eisai; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
 
Daniel John Renouf
Honoraria - Celgene; Celgene; Celgene; Celgene; Ipsen; Ipsen; Ipsen; Ipsen; SERVIER; SERVIER; SERVIER; SERVIER; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; SERVIER; SERVIER; SERVIER; SERVIER; Shire; Shire; Shire; Shire
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst)
 
Sharlene Gill
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Roche Canada; Roche Canada; Roche Canada; Roche Canada; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Amgen; Amgen; Amgen; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical